Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTA 402 Phase 3 Trial in Diabetic Kidney Disease
jRCT2080223898Phase 3Terminated
- Sponsor
- Kyowa Kirin
- Start
- May 2018
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic glomerulosclerosis comparing RTA 402 with Placebo (2 arms). Started May 2018; status: terminated.
02
Drugs
bardoxolone methyl
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on jRCT2080223898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223898.